CUE vs ETR · rev $9.3M vs P/E 28, rev $12.95B
Cue Biopharma (CUE) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
CUE currently screens at market cap $59.5M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the CUE and ETR stock pages for the full models.
Not investment advice.